Bodyline is a leading UK provider of clinically supported weight health programmes. With over 17 years of experience, we recognise that weight management has a huge impact on a person’s health and plays a crucial role in maintaining overall well-being. Weight has a significant effect on various aspects of well-being ranging from physical, emotional, social to mental health.
For a growing proportion of the UK population, controlling and managing weight can be incredibly difficult, especially when diet and exercise alone doesn’t appear to be having a positive effect. For those individuals who are struggling with weight gain, medical weight loss treatments and clinical support yield positive weight loss results.
Obesity is a challenging, complex, and controversial public health issue and is increasingly having negative consequences in the workplace. As a result, weight health at work is on many business’ agenda. Healthy weight employees improve wellbeing in the workplace, reduce costs and risks to the organisation, as well as prevent weight related illnesses.
One of the most effective ways to optimise workplace weight health is to commit to a corporate wellness solution that includes support plans, effective medical treatment and individual pathways based on the specific weight health needs. Partnering with a clinical weight loss and medical wellness service provider such as Bodyline, provides an opportunity to implement better occupational health strategies, gold standard treatment and workforce support throughout an organisation.
The increased availability of the ‘game changing’ NICE approve GLP-1 weight loss injections supports effective and safe treatment for those that are overweight or struggling with obesity. These, prescription only, weight loss injections are called GLP-1 (glucagon-like peptide-1) receptor agonists and are marketed for obesity under the brand names Wegovy (semaglutide) and Saxenda (liraglutide). GLP-1 is a hormone that is naturally produced in the intestines upon finishing a meal, signalling to the brain that the meal is finished and promoting the feeling of fullness. GLP-1 plays a role in regulating blood sugar levels and appetite. When mimicked with the help of weight loss injections, users consume less food, therefore less calories, allowing them to lose weight much easier and change their association with food. Mounjaro (tirepatide) will be the next weight loss injection to be launched in the UK. It will be the first approved combined glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 glucagon-like peptide-1 and has been clinically found to be more effective with weight loss results.
Bodyline has a UK wide scalable weight loss treatment infrastructure and access to a robust medication supply chain to support collaboration with partners such as employers, occupational health professionals, health insurance as well as other complementary weight health providers. We have success in providing gold standard clinical interventions and specialist support to reduce obesity in society and in the workplace.
Invest in treating and supporting weight health and improve your business performance
Contact our weight health customer services team to find out more about our corporate weight health solutions.
Book a meeting with our corporate partnership weight health team here.
Our corporate partnership weight health team will meet with you and provide an overview of Bodyline's weight health options and define scope for collaboration.
Bodyline's weight health corporate solution starts with a business audit or scoping session to understand how obesity is being managed currently and what if any clinical treatment and support is in place. We also gain an understanding of the risks of weight health to your clients or employees. From this information a tailored weight health collaboration proposal will be defined with deliverables, a detailed patient journey proposed, and when agreed, a contract signed off.
Bodyline supports the launch of Bodyline's medical weight health programme within your organisation and if required support with creating awareness within your client base. Activities can include amongst others training and education and generating wider market engagement through joint marketing.
At a patient level our specialist medical weight loss nurses engage and carry out a complete triage onboarding process. The aim of this process is to identify if medical weight loss is suitable for the patient and if so, which medication should be prescribed alongside a personalised holistic treatment plan.
Bodyline understand the value of a personalised supported patient weight loss journey and that extra support and medication dose changes will be required to reach weight loss goals.
Bodyline will also have agreed review meetings with the organisation based on what was outlined in the corporate weight loss programme plan. As the programme evolves, the plan will be refined to ensure deliverable and guarantee business relevance.
